Julie Krop

CIK 1643127 · Chief Medical Officer · last filed 2026-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

24

Lifetime Open-Market Net

-$168.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DMAC Chief Medical Officer $5.65 $0 2 2026-06-03
AQST Director $4.17 $0 6 2025-06-12
AMAG PHARMACEUTICALS, INC. (AMAG) Delisted Chief Medical Officer 73,044 -$168.4K 16 2020-03-04

Recent Filings · Page 3 of 3

24 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-10-20 AMAG PHARMACEUTICALS, INC. (AMAG) Delisted Sell (S) −4,938 -$122.5K EDGAR
2016-06-02 AMAG PHARMACEUTICALS, INC. (AMAG) Delisted Tax (F) −2,394 -$53.0K EDGAR
2016-03-02 AMAG PHARMACEUTICALS, INC. (AMAG) Delisted Grant (A) +9,000 $0 EDGAR
2015-06-03 AMAG PHARMACEUTICALS, INC. (AMAG) Delisted Grant (A) +22,000 $0 EDGAR
Showing 2124 of 24
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.